4
Changes in Ownership
Keros Therapeutics, Inc. Filed Acc 0001732369-26-000004
CHIEF EXECUTIVE OFFICER sold 7,015 shares at $16.17 ($113,433)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Seehra Jasbir CHIEF EXECUTIVE OFFICER | 2026-02-19 | Sale | −7,015 | $16.17 | $113,433 | 385,708 | D: show line 1 in the form |
| Open-market sales · 7,015 sh · avg $16.17 · $113,433 | |||||||
Loading xslF345X05/form4-02202026_040207.xml…